JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Riely
    Riely
  2. Ladanyi
    Ladanyi
  3. Arcila
    Arcila
  4. Rudin
    Rudin
  5. Kris
    Kris
  6. Offin
    Offin
  7. Drilon
    Drilon
  8. Rekhtman
    Rekhtman
  9. Yu
    Yu
  10. Paik
    Paik

Groups

  1. Department of Medicine (12)
  2. Solid Tumor Oncology Division (12)
  3. Thoracic Oncology (12)
  4. Department of Pathology and Laboratory Medicine (10)
  5. GSK Faculty (9)
  6. Human Oncology and Pathogenesis Program (9)
  7. Tow Center for Developmental Oncology (TCDO) (9)
  8. Weinberg Fellows (9)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (7)
Search Within
  1. "Gregory Riely"
Formats
  1. Journal Article (12)
Groups
  1. Department of Medicine (12)
  2. Solid Tumor Oncology Division (12)
  3. Thoracic Oncology (12)
  4. Department of Pathology and Laboratory Medicine (10)
  5. GSK Faculty (9)
  6. Human Oncology and Pathogenesis Program (9)

More Groups

People
  1. Gregory Riely (12)
  2. Marc Ladanyi (9)
  3. Charles Rudin (6)
  4. Maria Arcila (6)
  5. Mark Kris (5)
  6. Michael Offin (5)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (4)

More Years

Publishers
  1. American Society of Clinical Oncology (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Biomarker inference and the timing of next-generation sequencing in a multi-institutional, cross-cancer clinicogenomic data set
    Journal Article

    Kehl, K. L.; Lavery, J. A.; Brown, S.; Fuchs, H.; Riely, G.; Schrag, D.; Newcomb, A.; Nichols, C.; Micheel, C. M.; Bedard, P. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors
    Journal Article

    Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Erlotinib and trametinib in patients with EGFR-mutant lung adenocarcinoma and acquired resistance to a prior tyrosine kinase inhibitor
    Journal Article

    Luo, J.; Makhnin, A.; Tobi, Y.; Ahn, L.; Hayes, S. A.; Iqbal, A.; Ng, K.; Arcila, M. E.; Riely, G. J.; Kris, M. G.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • CNS metastases in patients with MET exon 14-altered lung cancers and outcomes with crizotinib
    Journal Article

    Offin, M.; Luo, J.; Guo, R.; Lyo, J. K.; Falcon, C.; Dienstag, J.; Wilkins, O.; Chang, J.; Rudin, C. M.; Riely, G.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of vemurafenib in patients with non–small-cell lung cancer with BRAF V600 mutation: An open-label, single-arm cohort of the histology-independent VE-Basket study
    Journal Article

    Subbiah, V.; Gervais, R.; Riely, G.; Hollebecque, A.; Blay, J. Y.; Felip, E.; Schuler, M.; Gonçalves, A.; Italiano, A.; Keedy, V.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Schoenfeld, A. J.; Plodkowski, A. J.; Odintsov, I.; Lu, D.; Lockwood, W. W.; Arcila, M. E.; Rudin, C. M.; Drilon, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology